Is Pfizer stock halal to invest in?

Company Name
Company Symbol
Exchange
Pfizer
PFE
NYSE
PFE
Halal
Pfizer
NYSE

Warning: The result may change based on other methodologies. As of the recent update on Tuesday 7th of February 2023 , is considered as Halal based on FTSE methodology. To access full report and unlock the detailed results with associated ratios for 5 halal investment methodologies, you can click below.

Detailed report based on FTSE methodology

Activity filter

Main Activity
Activity test result
Pharmaceuticals
PASS

Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Financial filter

Debt test

Total Debt
Interest free debt
Adjusted debt level
Total Asset
Debt Ratio
PASS or FAIL
$37,100,266,000
0
$37,100,266,000
$195,350,000,000
18.99%
PASS

Cash test

Cash
Cash Eq.
Short Term Investment
Total Asset
Cash & Eq. ratio
PASS or FAIL
$0
$1,298,000,000
$34,825,000,000
$195,350,000,000
18.5%
PASS

Acid test

Cash
Cash Eq.
Net Accounts Receivables
Total Asset
Quick ratio
PASS or FAIL
$0
$1,298,000,000
$16,076,000,000
$195,350,000,000
8.89%
PASS

Non permissible income filter

Net Interest Income (Expense) as non-Operating

Total Non permissible and doubtful income
Total revenue
Non permissible and doubtful income ratio
PASS or FAIL
-$823,000,000
$24,290,000,000
-3.39%
PASS